Sevasadan Niramay Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 16-12-2024
- Paid Up Capital ₹ 84.00 K
as on 16-12-2024
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 54.22%
(FY 2023)
- Profit 719.33%
(FY 2023)
- Ebitda 350.39%
(FY 2023)
- Net Worth 716.92%
(FY 2023)
- Total Assets 46.22%
(FY 2023)
About Sevasadan Niramay
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 84.00 K , as per Ministry of Corporate Affairs (MCA) records.
Lalit Somani, Mohamadali Borgave, Ravikant Patil, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100PN2021PTC199882
- Company No.
199882
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Mar 2021
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Kolhapur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Sevasadan Niramay?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ravikant Patil  | Director | 08-Mar-2022 | Current |
| Lalit Somani | Director | 08-Mar-2022 | Current |
| Mohamadali Borgave | Director | 26-Mar-2021 | Current |
| Dharmagaud Patil | Director | 26-Mar-2021 | Current |
Financial of Sevasadan Niramay.
Sevasadan Niramay Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 54.22% increase. The company also saw a substantial improvement in profitability, with a 719.33% increase in profit. The company's net worth Soared by an impressive increase of 716.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sevasadan Niramay?
Unlock access to Sevasadan Niramay's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Ichalkaranji Institute Of Medical SciencesActive 23 years 6 monthsLalit Somani and Mohamadali Borgave are mutual person
- Ichalkaranji Medical And Research Centre LimitedActive 25 years 5 months
Lalit Somani and Mohamadali Borgave are mutual person
- Ndg-Sevasadan Super Speciality & Diabete S Hospital LlpActive 5 years 6 months
Ravikant Patil is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sevasadan Niramay?
Sevasadan Niramay has a workforce of 111 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sevasadan Niramay, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sevasadan Niramay's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
